GNMSF - Genmab to purchase US-based biotech company ProfoundBio for $1.8 billion in all-cash deal April, 03 2024 04:17 AM Genmab A/S Dkk 2024-04-03 04:17:15 ET More on Genmab: Genmab: Recent Updates Support The Growth Narrative Genmab's Arbitration Loss: Best To Forgive And Forget (Rating Upgrade) Genmab announces ~$510M worth of share buybacks AbbVie/ Genmab win FDA priority review for lymphoma therapy For further details see: Genmab to purchase US-based biotech company ProfoundBio for $1.8 billion in all-cash deal